Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-10

Clinical Trial Update: Clonidine as Adjunct to Morphine for Neonatal Abstinence Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating clonidine as an adjunct to morphine for neonatal abstinence syndrome was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clonidine (clonidine)
  • Morphine (morphine)

Snippet

Sponsor: Hennepin County Medical Center, Minneapolis | Conditions: Neonatal Abstinence Syndrome | Phase 4 | Status: TERMINATED | Results posted: 2023-02-10